Visit the pressroom of the website for our headquarters in Denmark where you can access the latest corporate stock exchange announcements, an image library, interim and annual reports and other relevant communication from Novo Nordisk A/S.
Mail: NNCI_Communications@novonordisk.com
If you have concerns regarding any Novo Nordisk product, please call customer care at 1-800-465-4334 or email nnci-drugsafety@novonordisk.com. In the event of a medical emergency, contact your healthcare professional.